You searched for "tests"

1988 results found

True Cut – a dramatic biopsy from the world of surgery

True Cut is a stage play that asks: “What happens when things go wrong in healthcare?” It brings the hidden world of the operating theatre onto the theatre stage. ENT surgeon, David Alderson, talks about how the play came about....

Neuroimaging WG3. Neuroimaging as a window on the heterogeneity of tinnitus

Pim van Dijk and Sven Vanneste describe the hope that brain imaging techniques used for research will provide a better understanding of the heterogeneity of tinnitus through large-scale analysis. Their project will create a procedure whereby researchers can submit their...

FDA Approved Lenire Expands Number of US Clinics

Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.

Communication Disorders: a combined discipline of audiology and speech and language pathology – the Israeli perspective

Liat Kishon-Rabin provides an excellent summary of audiology training in Israel, encapsulating the development of audiology services in the country. Readers will be intrigued by the systematic approach taken to its development, and its pairing with speech and language pathology....

ENT in this issue...Multidisciplinary Teams

Joanne Rimmer, MBBS, MA(Hons) Cantab, FRCS(ORL-HNS), FRACS, Consultant Otolaryngologist / Rhinologist, Monash Health; Honorary Senior Lecturer, Department of Surgery, Monash University, Melbourne, Australia. E: rimmer.joanne@gmail.com The multidisciplinary team (MDT) has long been regarded as the gold standard in cancer care,...

From the editor SepOct 2021

As the pandemic evolves, the world seems to be divided into those countries that are fortunate enough to have good vaccine coverage and, hence, are able to open up their societies; and those who do not have an adequate vaccine roll-out and are having to live with significant restrictions or high levels of prevalent disease.

ENT & Audiology in this issue...The Outer Ear

Emma Stapleton, MBChB, FRCS (ORL-HNS), Consultant Otolaryngologist, Cochlear Implant and Skull Base Surgeon, Manchester Royal Infirmary, UK. E: emmastapleton@doctors.org.ukTwitter: @otolaryngolofox Priya Carling, AuD,Director and Consultant Audiologist,Kent Hearing Ltd, UK. E: priya@Kenthearing.com The outer ear is, we think, the unsung hero...

Is there increased cardiovascular risk with macrolide antibiotics?

This month’s Ed’s Choice delightfully reviews the potential cardiovascular consequences of long-term macrolide use in the treatment of chronic rhinosinusitis. This used to be one of my ‘go-to’ topics of conversation at home after a bad day at work, although...

Evidence-based hospital management of epistaxis

Epistaxis is the most common presentation to acute ENT services in the UK. However, there are currently no nationally accepted guidelines for its management. The British Rhinological Society, ENT UK and INTEGRATE (The National ENT Trainee Research Network) are working...

From the editor May/Jun 2026

Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. TW / X: @Voicedoctor_uk In our last edition, we featured the amazing work of Prof Shahed Quraishi and his ENT Masterclass® – the organisation...

Swallowing assessments of the future: the role of artificial intelligence

The future’s bright, the future’s Orange AI… If you Google ‘how much is AI worth?’, the AI overview tells you “The global artificial intelligence (AI) market size is estimated at approximately $244 billion to $391 billion in 2025 and is...

Global CI Collaborative: Futures Forum - Webinar Series

The Global CI Collaborative presents a five-part global leadership webinar series that will explore the future of cochlear implantation following the global pandemic.